115 related articles for article (PubMed ID: 6815381)
1. A feasibility study in the development of biological markers for ovarian cancer.
Waalkes TP; Rosenshein NB; Shaper JH; Ettinger DS; Woo KB; Paone JF; Gehrke CW
J Surg Oncol; 1982 Dec; 21(4):207-14. PubMed ID: 6815381
[TBL] [Abstract][Full Text] [Related]
2. Tumour markers in ovarian cancer.
van Nagell JR
Clin Obstet Gynaecol; 1983 Aug; 10(2):197-212. PubMed ID: 6193919
[No Abstract] [Full Text] [Related]
3. Multiple biological markers and breast carcinoma: a preliminary study in the detection of recurrent disease after primary therapy.
Waalkes TP; Abeloff MD; Ettinger DS; Woo KB; Gehrke CW; Mrochek JE
J Surg Oncol; 1981; 18(1):9-19. PubMed ID: 6116832
[TBL] [Abstract][Full Text] [Related]
4. Carcinoembryonic antigen and beta-human chorionic gonadotropin as serum markers for advanced urothelial malignancies.
Dexeus F; Logothetis C; Hossan E; Samuels ML
J Urol; 1986 Aug; 136(2):403-7. PubMed ID: 2426474
[TBL] [Abstract][Full Text] [Related]
5. Cancer antigen 125, tissue polypeptide antigen, carcinoembryonic antigen, and beta-chain human chorionic gonadotropin as serum markers of epithelial ovarian carcinoma.
Panza N; Pacilio G; Campanella L; Peluso G; Battista C; Amoriello A; Utech W; Vacca C; Lombardi G
Cancer; 1988 Jan; 61(1):76-83. PubMed ID: 2446734
[TBL] [Abstract][Full Text] [Related]
6. Carcinoembryonic antigen in ovarian epithelial cystadenocarcinomas: the prognostic value of tumor and serial plasma determinations.
van Nagell JR; Donaldson ES; Gay EC; Sharkey RM; Rayburn P; Goldenberg DM
Cancer; 1978 Jun; 41(6):2335-40. PubMed ID: 350376
[No Abstract] [Full Text] [Related]
7. Oncofetal antigens in ovarian cyst fluids.
Kraly DH; Koh SH; Hay DL; Cauchi MN
Gynecol Obstet Invest; 1984; 18(3):117-21. PubMed ID: 6208091
[TBL] [Abstract][Full Text] [Related]
8. Beta-human chorionic gonadotrophin and carcino-embryonic antigen in the management of ovarian carcinoma.
Stone M; Bagshawe KD; Kardana A; Searle F; Dent J
Br J Obstet Gynaecol; 1977 May; 84(5):375-9. PubMed ID: 889730
[TBL] [Abstract][Full Text] [Related]
9. Significance of CEA, AFP, SP1 and HCG as tumor markers in ovarian carcinoma.
Pulay T; Csömör S; Mészáros K; Szarka G; Csabay L; Szinnyai A
Neoplasma; 1987; 34(5):595-600. PubMed ID: 2447510
[TBL] [Abstract][Full Text] [Related]
10. Biologic markers in breast carcinoma. IV. Serum fucose-protein ratio. Comparisons with carcinoembryonic antigen and human chorionic gonadotrophin.
Waalkes TP; Gehrke CW; Tormey DC; Woo KB; Kuo KC; Synder J; Hansen H
Cancer; 1978 May; 41(5):1871-82. PubMed ID: 647632
[TBL] [Abstract][Full Text] [Related]
11. Carcinoembryonic antigen in ovarian cancer: correlation of concentrations in tumour tissue, cyst fluid, ascitic fluid and peripheral blood.
Khoo SK; Hill R; Daunter B; Mackay EV
Aust N Z J Obstet Gynaecol; 1982 May; 22(2):65-70. PubMed ID: 6958253
[No Abstract] [Full Text] [Related]
12. Tumor markers for ovarian cancer.
Bhattacharya M; Barlow JJ
Int Adv Surg Oncol; 1979; 2():155-76. PubMed ID: 95453
[TBL] [Abstract][Full Text] [Related]
13. The value of tumor markers in cancer of the ovary.
Cantarow WD; Stolbach LL; Bhattacharya M; Chatterjee SK; Barlow JJ
Int J Radiat Oncol Biol Phys; 1981 Aug; 7(8):1095-8. PubMed ID: 6170620
[No Abstract] [Full Text] [Related]
14. Multiple biochemical markers in patients with gynecologic malignancies.
Donaldson ES; van Nagell JR; Pursell S; Gay EC; Meeker WR; Kashmiri R; van deVoorde J
Cancer; 1980 Mar; 45(5):948-53. PubMed ID: 6167342
[TBL] [Abstract][Full Text] [Related]
15. Assessment of urinary beta-core fragment of human chorionic gonadotropin as a new tumor marker of lung cancer.
Yoshimura M; Nishimura R; Murotani A; Miyamoto Y; Nakagawa T; Hasegawa K; Koizumi T; Shii K; Baba S; Tsubota N
Cancer; 1994 Jun; 73(11):2745-52. PubMed ID: 7514953
[TBL] [Abstract][Full Text] [Related]
16. The significance of measurement of human placental lactogen, human chorionic gonadotropin, and carcinoembryonic antigen in patients with ovarian carcinoma.
Samaan NA; Smith JP; Rutledge FN; Schultz PN
Am J Obstet Gynecol; 1976 Sep; 126(2):186-9. PubMed ID: 183504
[TBL] [Abstract][Full Text] [Related]
17. The clinical significances of carcinoembryonic proteins in patients with ovarian carcinoma.
Tottori K; Takeuchi S
Nihon Sanka Fujinka Gakkai Zasshi; 1981 Jan; 33(1):142-50. PubMed ID: 6164739
[TBL] [Abstract][Full Text] [Related]
18. [Relationship between serum levels and immunohistological tissue levels of CA 125 and CEA in epithelial ovarian cancers: its implications for tumor cell type specificity].
Oishi T; Maruo T; Iwasaki M; Mochizuki M
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Sep; 38(9):1595-604. PubMed ID: 3464659
[TBL] [Abstract][Full Text] [Related]
19. Biologic markers and breast cancer.
Waalkes TP; Tormey DC
Semin Oncol; 1978 Dec; 5(4):434-44. PubMed ID: 83677
[No Abstract] [Full Text] [Related]
20. Serum concentrations of cancer antigen 125, placental alkaline phosphatase, cancer-associated serum antigen and free beta human chorionic gonadotrophin as prognostic markers for epithelial ovarian cancer.
Ind T; Iles R; Shepherd J; Chard T
Br J Obstet Gynaecol; 1997 Sep; 104(9):1024-9. PubMed ID: 9307529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
